XML 69 R37.htm IDEA: XBRL DOCUMENT v3.23.1
Equity-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Option Activity
A summary of stock options activity under the Plan as of March 31, 2023 and changes during three months ended March 31, 2023 is presented as follows:
SharesWeighted-Average Grant Date Fair Value per ShareWeighted-Average Exercise Price per ShareWeighted-Average Remaining Contractual Term (Years)
Outstanding at December 31, 2022
2,153,591 $2.70 $7.22 8.60
Forfeited(37,999)2.81 7.74 
Outstanding at March 31, 2023
2,115,592 $2.70 $7.21 8.30
Schedule of Nonvested Restricted Stock Units Activity
A summary of restricted stock units activity under the Plan as of March 31, 2023 and changes during the three months ended March 31, 2023 is presented as follows:
Restricted SharesWeighted-Average Grant Date Fair Value per ShareWeighted-Average Remaining Contractual Term (in Years)Aggregate Intrinsic Value
Unvested at December 31, 2022
2,282,778 $6.30 1.3$4,520 
Forfeited(96,944)7.19 
Unvested at March 31, 2023
2,185,834 $6.26 1.1$6,623 
Schedule of Stock Compensation Expense
The table below presents the equity-based compensation expense recorded during the following periods:
Three Months Ended
March 31, 2023March 31, 2022
Cost of Sales
Incentive Units$— $181 
Stock Options46 12 
Restricted Stock Units673 627 
Total cost of sales$719 $820 
Selling, general and administrative expenses
Incentive Units— 2,171 
Stock Options361 409 
Restricted Stock Units878 1,011 
Total selling, general and administrative expenses$1,239 $3,591 
Total equity-based compensation expense$1,958 $4,411